Edwards Lifesciences | EW - 销售和管理费用

股票价格

84.15

每天变化

4.43 5.56%

每月一次

1.79%

每年

10.67%

Q2 预测

82.35

金融业

USD

USD 13.7B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.74B

USD 1.81B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.34B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 49.08B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.13B

贸易债权人

USD 227.5M

应收帐款人

USD 912.1M

	销售和管理费用	更改		日
Abbott	USD 3.27B		138M	2026-03
Artivion	USD 55.75M		4.54M	2025-12
AtriCure	USD 78.34M		109K	2025-12
Baxter International	USD 761M		53M	2025-12
Becton, Dickinson and Co.	USD 1.39B		27M	2025-12
Boston Scientific	USD 1.83B		93M	2025-12
Cooper Companies	USD 373.1M		46.1M	2025-12
Dexcom	USD 299.9M		31.5M	2025-12
Edwards Lifesciences	USD 522.2M		80.7M	2026-03
Globus Medical	USD 318.48M		4.88M	2025-12
ICU Medical	USD 155.81M		3.04M	2025-12
Inogen	USD 43.77M		510K	2024-06
Insulet	USD 331.4M		16.2M	2025-12
Integra LifeSciences	USD 156.45M		12.6M	2025-12
Intuitive Surgical	USD 613.3M		73.8M	2026-03
J&J	USD 6.03B		719M	2026-03
Masimo	USD 128M		11.6M	2025-12
Medtronic	2.97B		159M	2025-09
Merit Medical Systems	USD 114.83M		7.45M	2025-12
Stryker	USD 2.14B		150M	2025-12
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Teleflex	USD 222.37M		59.4M	2025-12
Zimmer Biomet Holdings	USD 855.7M		44.3M	2025-12